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Abstract
Background:  Myocarditis can develop as a complication of various infections and is most
commonly linked to enterovirus infections. Myocarditis is rarely associated with bacterial
infections; salmonellosis and shigellosis have been the most frequently reported bacterial cause.
We report a case of myocarditis related to Campylobacter jejuni enteritis.
Case Presentation: A 30-year-old previously healthy man presented with a history of prolonged
chest pain radiating to the jaw and the left arm. Five days prior to the onset of chest pain, he
developed bloody diarrhea, fever and chills. Creatine kinase (CK) and CK-MB were elevated to 289
U/L and 28.7 µg/L. Troponin I was 30.2 µg/L. The electrocardiogram (ECG) showed T wave
inversion in the lateral and inferior leads. The chest pain resolved within 24 hours of admission.
The patient had a completely normal ECG stress test. The patient was initiated on ciprofloxacin
500 mg po bid when Campylobacter jejuni was isolated from the stool. Diarrhea resolved within 48
hours of initiation of ciprofloxacin. The diagnosis of Campylobacter enteritis and related myocarditis
was made based on the clinical and laboratory results and the patient was discharged from the
hospital in stable condition.
Conclusion: Myocarditis can be a rare but severe complication of infectious disease and should
be considered as a diagnosis in patients presenting with chest pain and elevated cardiac enzymes in
the absence of underlying coronary disease. It can lead to cardiomyopathy and congestive heart
failure. There are only a few reported cases of myocarditis associated with Campylobacter infection.
Background
Myocarditis can result as a complication of various infec-
tious diseases. The overall incidence of myocarditis is
unknown but autopsy results have shown the frequency
to be about 0.5 % to 5%.[1] Sensitive molecular tech-
niques, such as polymerase chain reaction and in-situ
hybridization, have determined infections due to entero-
virus to be common causes of myocarditis in North Amer-
ica and Western Europe.[2,3] Myocarditis is rarely
associated with bacterial infections; salmonellosis and
shigellosis have been the most frequently reported cause
of bacterial myocarditis.[4] There are a few case reports of
myocarditis as a complication of Campylobacter jejuni
infection from Europe only. [4–7]
We present a case of Campylobacter jejuni-related myocar-
ditis with complete recovery. We believe this is the first
reported occurrence in North America.
Case Presentation
A 30-year-old previously healthy man presented with a 5-
hour history of constant, retrosternal chest pain radiating
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to the jaw and the left arm. This was associated with short-
ness of breath and diaphoresis. Other than hypertension
controlled with ramipril, he did not have other coronary
artery disease risk factors. He exercised vigorously every
day. Five days prior to the hospital admission, he devel-
oped bloody diarrhea, fever and chills. A few days before
the onset of diarrhea, he had eaten mussels from a local
restaurant.
On examination, he was in mild distress. Blood pressure
was 145/101; heart rate, 90 beats per minute; respiratory
rate, 18 per minute; temperature, 37.3°C and the O2 satu-
ration measured 99% while breathing room air. Cardiac
examination was normal without any extra sounds, mur-
murs, or pericardial rubs. Respiratory, abdominal and
musculoskeletal examinations were normal.
Laboratory investigations revealed normal blood counts
and serum electrolytes. Creatine kinase (CK) and CK-MB
were elevated to 289 U/L (reference range, 0–225) and
28.7 µg/L (reference range, <10). Troponin I was 30.2 µg/
L (reference range, 0 – 0.5). Electrocardiogram (ECG)
showed T wave inversion in the lateral and inferior leads.
The patient was treated with acetylsalicylate acid (ASA),
topical nitroglycerine, oral metoprolol and was admitted
to the coronary care unit for intensive cardiac monitoring.
Over the course of 24 hours, the chest pain resolved and
the patient remained hemodynamically stable through-
out the 5-day hospital stay. On the second day in hospital,
CK normalized but troponin I remained elevated at 14.4
µg/L. Transthoracic echocardiography showed no pericar-
ditis or area of hypokinesis. There was no sign of myocar-
dial infarction or arrhythmia. The patient had a
completely normal ECG stress test.
The bloody diarrhea persisted during the first 72 hours of
hospitalization. The patient was initiated on ciprofloxacin
500 mg po bid when Campylobacter jejuni was isolated
from the stool but the blood culture was sterile. C. difficile
toxin, parasite and virus were not detected from the stool.
No virus was isolated from the throat washing culture.
Flexible sigmoidoscopy confirmed the presence of mild
colitis.
The diagnosis of Campylobacter enteritis and related myo-
carditis was made based on the clinical and laboratory
results. Shortly after initiating the antibiotic therapy, the
diarrhea resolved and the patient recovered completely.
After finishing a 5-day course of ciprofloxacin, the patient
was discharged from the hospital in a stable condition.
Discussion
A diagnosis of myocarditis should be contemplated when
a patient presents with unexplained congestive heart fail-
ure, or with chest pain and elevated cardiac enzyme levels
in the absence of coronary disease or coronary spasm.[3]
The pathophysiology of myocarditis in humans is not
well understood, however, several theories have been
developed. It may be due to post-infectious autoimmune
mechanism, which can result in myocyte damage.[8]
Murine and other animal models have demonstrated
direct viral proliferation within the myocytes and destruc-
tion of the host cells.[9]
Clinical manifestations of myocarditis are variable and in
part may depend on the underlying etiology. Patients may
present with chest pain, arrhythmia, and/or congestive
heart failure, one to two weeks following symptoms of
gastroenteritis or a viral illness. Our patient presented
with a 5-day history of bloody diarrhea due to stool cul-
ture confirmed Campylobacter jejuni. He developed severe,
steady chest pain in the absence of underlying coronary
artery disease. It is plausible that he developed myocardi-
tis secondary to Campylobacter jejuni and not virus as the
viral cultures of the stool and throat washing did not grow
any organism. Evidence for myocyte injury is further pro-
vided by the changes in cardiac enzymes. CK and CK-MB
were slightly elevated with a more dramatic rise in tro-
ponin-I to a peak of 30 µg/L. This parallels the profile of
enzyme changes described in a similar reported case of C.
jejuni myocarditis wherein troponin-I peaked at 58 µg/
L.[4] Troponin I has been cited as the most sensitive car-
diac enzyme marker in patients with clinically suspected
myocarditis and has been found to correlate with immu-
nohistologic assessments.[10,11]
In our patient, chest pain developed within 4 days follow-
ing the onset of diarrhea. This is similar to the cases previ-
ously described, in which cardiac symptoms occurred 2
and 3 days respectively, after the first gastrointestinal com-
plaints.[4,5] As suggested by Westling, this may indicate
an immediate influence of C. jejuni on myocytes through
either direct damage to cells by bacteria or circulating tox-
ins. This is unlike the more typical enterovirus cases in
which myocarditis can occur one to several weeks
between recovery from the infection and development of
myocarditis, suggesting a post-viral immune-mediated
mechanism.[3]
Endomyocardial biopsy is recommended in a few circum-
stances as myocarditis cannot be reliably diagnosed clini-
cally or with routine biochemical laboratory tests.[12] It is
crucial to definitively establish the diagnosis of myocardi-
tis, if the patient fails to improve for consideration of
institution of immunosuppressive therapy and to ascer-
tain prognosis.[13]Publish with BioMed Central    and   every 
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Conclusion
Myocarditis is rare but can be a severe complication of
infectious disease and should be considered as a diagnosis
in patients presenting with chest pain and elevated cardiac
enzymes in the absence of coronary disease. Myocarditis
can lead to cardiomyopathy and congestive heart failure.
It has been most commonly associated with enterovirus.
Occasionally it has been connected with bacterial enteritis
and there are only a few reported cases of myocarditis due
to Campylobacter infection.
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